Cefixime
Back to searchMolecule Structure
Scientific Name
Cefixime
Description of the Drug
Cefixime is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00671
http://www.drugbank.ca/drugs/DB00671
Brand Name(s)
Cefixime, Cefspan, Oroken, Suprax
Company Owner(s)
Alkem Laboratories Ltd, Lederle Laboratories Div American Cyanamid Co, Lupin Pharmaceuticals Inc, Sandoz Inc, Aurobindo Pharma Ltd, Belcher Pharmaceuticals Llc, Lupin Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL24945 | ||
Human Metabolome Database | HMDB0014809 | ||
DrugBank | DB00671 | ||
PubChem: Thomson Pharma | 15404783 | 14833440 | |
PubChem | 5362065 | ||
NMRShiftDB | 60027565 | ||
Nikkaji | J22.201A | ||
PDBe | C04 | ||
BindingDB | 84007 | ||
DrugCentral | 537 | ||
Brenda | 248730 | ||
ChemicalBook | CB51270100 | CB4210362 | |
Guide to Pharmacology | 10898 | ||
rxnorm | SUPRAX | CEFIXIME | CEFIXIME ANHYDROUS |
PubChem: Drugs of the Future | 12012851 | ||
KEGG Ligand | C06881 | ||
ChEBI | 472657 | ||
ZINC | ZINC000004468778 |